Company intelligence / Profile preview

Autogon AI

Ownership: Private
Development stage: Other

Overview

Autogon AI offers a no-code platform that enables businesses to build and deploy custom artificial intelligence solutions without coding. Their patented algorithms have supported applications in medical research—including disease detection and novel drug discovery—but the core business is providing accessible automation tools across industries. The system allows users to upload datasets or use prebuilt APIs to generate functional machine learning models rapidly[1][2].

Industry: Drug Discovery Services

Partnerships

No major pharmaceutical or biotech partnerships specifically identified. The company works with enterprise clients across sectors including financial services[2].

Beyond the preview

Go deeper on Autogon AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Autogon AI.

Explore the full profile